Neural stimulation for Parkinson's disease: Current therapies and future directions

Expert Review of Neurotherapeutics

Volumn 6, Issue 1, 2006, Pages 101-109

  Neimat, Joseph S ^a   Hamani, Clement ^a   Lozano, Andres M ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Deep brain stimulation; Movement disorders; Parkinson's disease; Subthalamic nucleus

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; APOMORPHINE; CARBIDOPA PLUS LEVODOPA; LEVODOPA; PETHIDINE;

AKINESIA; BRAIN DEPTH STIMULATION; BRAIN HEMORRHAGE; BRAIN REGION; CEREBROSPINAL FLUID FISTULA; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE DEFECT; DEPRESSION; DISEASE COURSE; DISEASE PREDISPOSITION; DYSKINESIA; FOLLOW UP; GAIT DISORDER; GLOBUS PALLIDUS; HUMAN; INFECTION COMPLICATION; MENINGITIS; MENTAL DISEASE; MICROELECTRODE; MOTOR ACTIVITY; MOTOR CORTEX; MOTOR DYSFUNCTION; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATIENT SELECTION; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PHLEBITIS; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; REVIEW; RISK FACTOR; SPEECH DISORDER; SUBTHALAMIC NUCLEUS; SURGICAL TECHNIQUE; TARGET ORGAN; TREMOR;

BRAIN; CLINICAL TRIALS; ELECTRIC STIMULATION THERAPY; EXPERT TESTIMONY; HUMANS; PARKINSON DISEASE; PATIENT SELECTION; RISK;

EID: 33645863776     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.6.1.101     Document Type: Review

References (78)

1. Twelves D, Perkins KS, Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov. Disord. 18(1), 19-31 (2003).
2. Schoenberg BS. Descriptive epidemiology of Parkinson's disease: disease distribution and hypothesis formulation. Adv. Neurol. 45, 277-283 (1987).
3. Tanner CM, Goldman SM. Epidemiology of Parkinson's disease. Neurol. Clin. 14(2), 317-335 (1996).
4. Schrag A, Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain 123(Pt 11), 2297-2305 (2000).
5. Poole JL. Psychosurgery in older people. J. Am. Geriatr. Soc. 2, 456-466 (1954).
6. Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson's disease. Appl. Neurophysiol. 50(1-6), 344-346 (1987).
7. Siegfried J. Effect of stimulation of the sensory nucleus of the thalamus on dyskinesia and spasticity. Rev. Neurol. 142(4), 380-333 (1986).
8. Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 35(6), 1126-1129 (1994).
9. Stanzione P, Mazzone P, Peppe A, Pierantozzi M, Stefani A. Antiparkinsonian and antilevodopa-induced dyskinesia effects obtained by stimulating the same site within the GPi in PD. Neurology 51(6), 1776-1777 (1998).
10. Kumar R, Lang AE, Rodriguez-Oroz MC, Lozano AM, Limousin P. Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease. Neurology 55(12 Suppl. 6), S34-S39 (2000).
11. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345(8942), 91-95 (1995).
12. Mazzone P, Lozano A, Stanzione P, Galati S, Scarnati E. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport 16(17), 1877-1881 (2005).
13. Canavero S, Bonicalzi V. Cortical stimulation for parkinsonism. Arch. Neurol. 61(4), 606 (2004).
14. Langston JW, Ballard PA. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N. Engl. J. Med. 309(5), 310 (1983).
15. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219(4587), 979-980 (1983).
16. Kolata G. Monkey model of Parkinson's disease. Science 220(4598), 705 (1983).
17. Ballard PA, Tetrud JW, Langston JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35(7), 949-956 (1985).
18. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12(10), 366-375 (1989).
19. Fénelon G, François C, Percheron G, Yelnik J. Topographic distribution of pallidal neurons projecting to the thalamus in macaques. Brain Res. 520(1-2), 27-35 (1990).
20. Mengual E, de las Heras S, Erro E, Lanciego JL, Giménez-Amaya JM. Thalamic interaction between the input and the output systems of the basal ganglia. J. Chem. Neuroanat. 16(3), 187-200 (1999).
21. Hammond C, Rouzaire-Dubois B, Féger J, Jackson A, Crossman AR. Anatomical and electrophysiological studies on the reciprocal projections between the subthalamic nucleus and nucleus tegmenti pedunculopontinus in the rat. Neuroscience 9(1), 41-52 (1983).
22. Obeso JA, Rodriguez MC, DeLong MR. Basal ganglia pathophysiology. A critical review. Adv. Neurol. 74, 3-18 (1997).
23. Obeso JA, Rodríguez-Oroz MC, Rodríguez M, Lanciego JL, Artieda J. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci. 23(Suppl. 10), S8-S19 (2000).
24. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 123 (Pt 9), 1767-1783 (2000).
25. Mink JW, Thach WT. Basal ganglia motor control. I. Nonexclusive relation of pallidal discharge to five movement modes. J. Neurophysiol. 65(2), 273-300 (1991).
26. Mink JW, Thach WT. Basal ganglia motor control. II. Late pallidal timing relative to movement onset and inconsistent pallidal coding of movement parameters J. Neurophysiol. 65(2), 301-329 (1991).
27. Mink JW, Thach WT. Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement J. Neurophysiol. 65(2), 330-351 (1991).
28. Benabid AL, Benazzous A, Pollak P. Mechanisms of deep brain stimulation. Mov. Disord. 17(Suppl. 3), S73-S74 (2002).
29. Dostrovsky JO, Levy R, Wu JP, Hutchison WD, Tasker RR, Lozano AM. Microstimulation-induced inhibition of neuronal firing in human globus pallidus J. Neurophysiol. 84(1), 570-574 (2000).
30. Filali M, Hutchison WD, Palter VN, Lozano AM, Dostrovsky JO. Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus. Exp. Brain Res. 156(3), 274-281 (2004).
31. Welter ML, Houeto JL, Bonnet AM, Bejjani PB, Mesnage V. Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients. Arch. Neurol. 61(1), 89-96 (2004).
32. Benazzouz A, Hallett M. Mechanism of action of deep brain stimulation. Neurology 55(12 Suppl. 6), S13-S16 (2000).
33. Anderson ME, Postupna N, Ruffo M. Effects of high-frequency stimulation in the internal globus pallidus on the activity of thalamic neurons in the awake monkey. J. Neurophysiol. 89(2), 1150-1160 (2003).
34. Hashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J. Neurosci. 23(5), 1916-1923 (2003).
35. Stefani A, Fedele E, Galati S, Pepicelli O, Frasca S. Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in Parkinson's disease patients. Ann. Neurol. 57(3), 448-452 (2005).
36. McIntyre CC, Savasta M, Kerkerian-Le Goff L, Vitek JL. Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin. Neurophysiol. 115(6), 1239-1248 (2004).
37. McIntyre CC, Grill WM, Sherman DL, Thakor NV. Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition. J. Neurophysiol. 91(4), 1457-1469 (2004).
38. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S. Core assessment program for intracerebral transplantations (CAPIT). Mov. Disord. 7(1), 2-13 (1992).
39. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD) Mov. Disord. 14(4), 572-584 (1999).
40. Pahwa R, Wilkinson SB, Overman J, Lyons KE. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with parkinson's disease. Stereotact. Funct. Neurosurg. 83(2-3), 80-83 (2005).
41. Rossi P, Colosimo C, Moro E, Tonali P, Albanese A. Acute challenge with apomorphine and levodopa in Parkinsonism. Eur. Neurol. 43(2), 95-101 (2000).
42. Hughes AJ, Lees AJ, Stern GM. Challenge tests to predict the dopaminergic response in untreated Parkinson's disease. Neurology 41(11), 1723-1725 (1991).
43. Olanow CW. Magnetic resonance imaging in parkinsonism. Neurol. Clin. 10(2), 405-20 (1992).
44. Saint-Cyr JA, Hoque T, Pereira LC, Dostrovsky JO, Hutchison WD. Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging. J. Neurosurg. 97(5), 1152-1166 (2002).
45. Committee MotUD. Unified Parkinson's disease rating scale. In: Recent Developments in Parkinson's disease. Fahn S, Elton RL (Eds). Macmillan Healthcare, NJ, USA (1986).
46. Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM,. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 337(8738), 403-406 (1991).
47. Krack P, Pollak P, Limousin P, Benazzouz A, Benabid AL. Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease Lancet. 350(9092), 1675 (1997).
48. Krack P, Limousin P, Benabid AL, Pollak P. Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease Lancet. 350(9092), 1676 (1997).
49. Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study Neurosurgery 45(6), 1375-1382 (1999).
50. Peppe A, Pierantozzi M. Bassi A, Altibrandi MG, Brusa L. Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson's disease. J. Neurosurg. 101(2), 195-200 (2004).
51. Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 128(Pt 10), 2240-2249 (2005).
52. Ondo WG, Bronte-Stewart H. The north american survey of placement and adjustment strategies for deep brain stimulation. Stereotact. Funct. Neurosurg. 83(4), 142-147 (2005).
53. Benabid AL, Krack PP, Benazzouz A, Limousin P, Koudsie A, Pollak P. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology 55(12 Suppl. 6), S40-S44 (2000).
54. Henderson JM. Frameless localization for functional neurosurgical procedures: a preliminary accuracy study. Stereotact. Funct. Neurosurg. 82(4), 135-141 (2004).
55. Fitzpatrick JM, Konrad PE, Nickele C, Cetinkaya E, Kao C. Accuracy of customized miniature stereotactic platforms. Stereotact. Funct. Neurosurg. 83(1), 25-31 (2005).
56. Eskandar E, Shinobu LA, Penney JBJ, Cosgrove GR. Non-microelectrode guided stereotactic pallidotomy for Parkinson's disease: surgical technique and results. Stereotact. Funct. Neurosurg. 72(2-4), 245 (1999).
57. Hariz MI, Fodstad H. Do microelectrode techniques increase accuracy or decrease risks in pallidotomy and deep brain stimulation? A critical review of the literature. Stereotact. Funct. Neurosurg. 72(2-4), 157-169 (1999).
58. Andrade-Souza YM, Schwalb JM, Hamani C, Eltahawy H, Hoque T. Comparison of three methods of targeting the subthalamic nucleus for chronic stimulation in Parkinson's disease. Neurosurgery. 56 (Suppl. 2), 360-368 (2005).
59. Nowinski WL, Belov D, Pollak P, Benabid AL. A probabilistic functional atlas of the human subthalamic nucleus. Neuroinformatics 2(4), 381-398 (2004).
60. Hamani C, Richter E, Schwalb JM, Lozano AM. Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature. Neurosurgery. 56(6), 1313-1321 (2005).
61. Berney A, Vingerhoets F, Perrin A, Guex P, Villemure JG,. Effect on mood of subthalamic deep brain stimulation for Parkinson's disease: a consecutive series of 24 patients Neurology 53(9), 1427-1429 (2002).
62. Piasecki SD, Jefferson JW. Psychiatric complications of deep brain stimulation for Parkinson's disease. J. Clin. Psych. 65(6), 845-859 (2004).
63. Funkiewiez A, Ardouin C, Krack P, Fraix V, Van Blercom N. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease Mov. Disord. 18(5), 524-530 (2003).
64. Yamamoto M, Jimbo M, Ide M, Tanaka N, Umebara Y, Hagiwara S. Postoperative neurosurgical infection and antibiotic prophylaxis. Neurol. Med. Chir (Tokyo). 32(2), 72-79 (1992).
65. Gentil M, Garcia-Ruiz P, Pollak P, Benabid AL. Effect of bilateral deep-brain stimulation on oral control of patients with parkinsonism. Eur. Neurol. 44(3), 147-152 (2000).
66. Dromey C, Kumar R, Lang AE, Lozano AM. An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Mov. Disord. 15(6), 1132-1138 (2000).
67. Saint-Cyr JA, Trépanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 123(Pt 10), 2091-108 (2000).
68. Santens P, De Letter M, Van Borsel J, De Reuck J, Caemaert J. Lateralized effects of subthalamic nucleus stimulation on different aspects of speech in Parkinson's disease. Brain Lang. 87(2), 253-258 (2003).
69. Burkhard PR, Vingerhoets FJ, Berney A, Bogousslavsky J, Villemure JG, Ghika J. Suicide after successful deep brain stimulation for movement disorders. Neurology 63(11), 2170-2172 (2004).
70. Nandi D, Liu X, Winter JL, Aziz TZ, Stein JF. Deep brain stimulation of the pedunculopontine region in the normal non-human primate. J. Clin. Neurosci. 9(2), 170-174 (2002).
71. Jenkinson N, Nandi D, Miall RC, Stein JF, Aziz TZ. Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey. Neuroreport 15(17), 2621-2624 (2004).
72. Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport 16(17), 1883-1887 (2005).
73. Katayama Y, Fukaya C, Yamamoto T. Control of poststroke involuntary and voluntary movement disorders with deep brain or epidural cortical stimulation. Stereotact. Funct. Neurosurg. 69(1-4 Pt 2), 73-79 (1997).
74. Garcia-Larrea L, Peyron R, Mertens P, Gregoire MC, Lavenne F. Electrical stimulation of motor cortex for pain control: a combined PET-scan and electrophysiological study. Pain 83(2), 259-273 (1999).
75. Canavero S, Paolotti R, Bonicalzi V, Castellano G, Greco-Crasto S,. Extradural motor cortex stimulation for advanced Parkinson's disease. Report of two cases. J. Neurosurg. 97(5), 1208-1211 (2002).
76. Canavero S, Paolotti R. Extradural motor cortex stimulation for advanced Parkinson's disease: case report. Mov. Disord. 15(1), 169-171 (2000).
77. Nakao N, Nakai E, Nakai K, Itakura T. Ablation of the subthalamic nucleus supports the survival of nigral dopaminergic neurons after nigrostriatal lesions induced by the mitochondrial toxin 3-nitropropionic acid. Ann. Neurol. 45(5), 640-651 (1999).
78. Hilker R, Portman AT, Voges J, Staal MJ, Burghaus L. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J. Neurol. Neurosurg. Psych. 76(9), 1217-1221 (2005).